Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol and beta-2 adrenergic pathway effects on skeletal muscle glucose uptake in healthy men
2018-004245-16Phase 2Completed
- Sponsor
- Maastricht University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of clenbuterol in type 2 diabetes mellitus (T2DM), sponsored by Maastricht University. Primary endpoint: Insulin-stimulated peripheral glucose disposal (Rd). Started May 2019; status: completed.
02
Drugs
clenbuterol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-004245-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004245-16.